Original Research

Coprescribed Benzodiazepines in Older Adults Receiving Antidepressants for Anxiety and Depressive Disorders: Association With Treatment Outcomes

Helene Altmann, Sarah T. Stahl, Marie Anne Gebara, Eric J. Lenze, Benoit H. Mulsant, Daniel M. Blumberger, Charles F. Reynolds III, and Jordan F. Karp

J Clin Psychiatry 2020;81(6):20m13283

Original Research

To Be Continued? Long-Term Treatment Effects of Antidepressant Drug Classes and Individual Antidepressants on the Risk of Developing Dementia: A German Case-Control Study

Claudia Bartels, Michael Belz, Jonathan Vogelgsang, Philipp Hessmann, Jens Bohlken, Jens Wiltfang, and Karel Kostev

J Clin Psychiatry 2020;81(5):19m13205

Original Research

Association of Benzodiazepines and Antidepressants With 180-Day Mortality Among Patients With Dementia Receiving Antipsychotic Pharmacotherapy: A Nationwide Registry-Based Study

Ane Nørgaard, Christina Jensen-Dahm, Christiane Gasse, Theresa Wimberley, Elsebet Steno Hansen, and Gunhild Waldemar

J Clin Psychiatry 2020;81(4):19m12828

Original Research

Early Improvements of Individual Symptoms With Antipsychotics Predict Subsequent Treatment Response of Neuropsychiatric Symptoms in Alzheimer’s Disease: A Re-Analysis of the CATIE-AD Study

Tomoyuki Nagata, Shunichiro Shinagawa, Kazunari Yoshida, Yoshihiro Noda, Masahiro Shigeta, Masaru Mimura, and Shinichiro Nakajima

J Clin Psychiatry 2020;81(2):19m12961

Original Research

The Value of Neuropsychological Assessment in the Differentiation Between Behavioral Variant Frontotemporal Dementia and Late-Onset Psychiatric Disorders

Jozefien M. Overbeek, Nicole Korten, Flora Gossink, Jay Fieldhouse, Marleen van de Beek, Lianne Reus, Annemieke Dols, Yolande Pijnenburg, and Sigfried Schouws

J Clin Psychiatry 2020;81(1):19m12811

Meta-Analysis

Exercise Intervention for Late-Life Depression: A Meta-Analysis

Sivan Klil-Drori, Adi J. Klil-Drori, Shamira Pira, and Soham Rej

J Clin Psychiatry 2020;81(1):19r12877

Original Research

Real-World Effectiveness of Ramelteon and Suvorexant for Delirium Prevention in 948 Patients With Delirium Risk Factors

Kotaro Hatta, Yasuhiro Kishi, Ken Wada, Takashi Takeuchi, Naoko Hashimoto, Kiyoko Suda, Toshihiro Taira, Kazuo Tsuchida, Takashi Ohmori, Nobuya Akizuki, Yuko Nishio, Yukiko Nakanishi, Chie Usui, Akiko Kurata, Naoki Horikawa, Hiroshi Eguchi, Shigeo Ito, Hitoshi Muto, Hiroyuki Nakamura, and Naohisa Uchimura

J Clin Psychiatry 2020;81(1):19m12865

Academic Highlights

Current and Emerging Solutions to Challenges in the Management of Alzheimer’s Disease

Alireza Atri, Danielle Goldfarb, Simon Sheard, and Lynn Shaughnessy

J Clin Psychiatry 2019;80(6):MS18002AH3C

Original Research

Prescription Opioid Misuse in US Older Adults: Associated Comorbidities and Reduced Quality of Life in the National Epidemiologic Survey of Alcohol and Related Conditions-III

Ty S. Schepis and Sean Esteban McCabe

J Clin Psychiatry 2019;80(6):19m12853

Original Research

The Effect of Antipsychotic Treatment on Recurrent Venous Thromboembolic Disease: A Cohort Study

Augusto Ferraris, Alejandro G. Szmulewicz, M. Lourdes Posadas-Martínez, Marina Alonso Serena, Fernando J. Vazquez, and Federico Angriman

J Clin Psychiatry 2019;80(5):18m12656